Vortioxetine hydrobromide troban Smiles: C/C(=C(\CCOP(O)(O)=O)/SC(=O)C1C=CC=CC=1)/N(CC1=CN=C(C)N=C1N)C=O

Smiles: C/C(=C(\CCOP(O)(O)=O)/SC(=O)C1C=CC=CC=1)/N(CC1=CN=C(C)N=C1N)C=O

42-dodecamethyl-15

It has selectivity > 1000-fold over 13 other HMTs and selected representatives of kinases

Solubility: DMSO: 94 mg/mL(198

Vortioxetine hydrobromide troban Smiles: C/C(=C(\CCOP(O)(O)=O)/SC(=O)C1C=CC=CC=1)/N(CC1=CN=C(C)N=C1N)C=OVortioxetine, also known as Lu AA21004, is an atypical antidepressant, and was approved in 2013 by the U. S. FDA for the treatment of major depressive disorder (MDD) in adults. Vortioxetine is a so called "serotonin modulator and stimulator." It has been shown to possess the following pharmacological actions: Serotonin transporter (SERT) blocker (i. e. serotonin reuptake inhibitor (SRI)) Ki (binding affinity) = 1. 6 nM, IC50 = 5. 4 nM; Norepinephrine